A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)

Summary

This is a research trial testing DUR-928 (an experimental medication). The purpose of the trial is to assess whether treatment with DUR-928 has any effect on the treatment of Primary Sclerosing Cholangitis (PSC). This trial will also assess safety (side effects).

Timeline

Start

2018-01-22

Primary completion

2019-01-31

Completion

2019-01-31

Outcome

Outcome not reported

Stopped (Enrollment): “poor enrollment”

Drugs

Indications